TP53INP1
Basic information
Region (hg38): 8:94925972-94949378
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TP53INP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 0 |
Variants in TP53INP1
This is a list of pathogenic ClinVar variants found in the TP53INP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-94930489-T-C | not specified | Uncertain significance (Oct 06, 2022) | ||
8-94930495-C-T | not specified | Uncertain significance (Dec 05, 2024) | ||
8-94930532-T-G | not specified | Uncertain significance (Dec 11, 2023) | ||
8-94930561-A-C | not specified | Uncertain significance (Jun 10, 2024) | ||
8-94930570-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
8-94930571-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
8-94930573-C-G | not specified | Uncertain significance (Nov 21, 2023) | ||
8-94930578-G-C | not specified | Uncertain significance (Dec 19, 2022) | ||
8-94930594-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
8-94930633-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
8-94930634-G-A | not specified | Uncertain significance (May 24, 2024) | ||
8-94930657-A-T | not specified | Uncertain significance (Dec 03, 2024) | ||
8-94930699-T-C | not specified | Uncertain significance (Jul 08, 2022) | ||
8-94939938-T-C | not specified | Uncertain significance (May 27, 2022) | ||
8-94940019-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
8-94940029-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
8-94940029-G-C | not specified | Uncertain significance (Apr 12, 2023) | ||
8-94940038-T-C | not specified | Uncertain significance (Sep 14, 2021) | ||
8-94940100-T-C | not specified | Uncertain significance (Apr 20, 2024) | ||
8-94940109-C-A | not specified | Uncertain significance (Apr 07, 2023) | ||
8-94940124-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
8-94940158-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
8-94940213-G-C | not specified | Uncertain significance (Sep 04, 2024) | ||
8-94940871-T-C | not specified | Likely benign (Jul 19, 2023) | ||
8-94940888-G-C | not specified | Uncertain significance (Dec 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TP53INP1 | protein_coding | protein_coding | ENST00000342697 | 3 | 23440 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000466 | 0.684 | 125712 | 0 | 36 | 125748 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.337 | 123 | 134 | 0.918 | 0.00000689 | 1616 |
Missense in Polyphen | 34 | 39.236 | 0.86656 | 470 | ||
Synonymous | 0.268 | 40 | 42.2 | 0.947 | 0.00000191 | 428 |
Loss of Function | 0.797 | 6 | 8.51 | 0.705 | 3.60e-7 | 109 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000786 | 0.000760 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Antiproliferative and proapoptotic protein involved in cell stress response which acts as a dual regulator of transcription and autophagy. Acts as a positive regulator of autophagy. In response to cellular stress or activation of autophagy, relocates to autophagosomes where it interacts with autophagosome-associated proteins GABARAP, GABARAPL1/L2, MAP1LC3A/B/C and regulates autophagy. Acts as an antioxidant and plays a major role in p53/TP53-driven oxidative stress response. Possesses both a p53/TP53-independent intracellular reactive oxygen species (ROS) regulatory function and a p53/TP53-dependent transcription regulatory function. Positively regulates p53/TP53 and p73/TP73 and stimulates their capacity to induce apoptosis and regulate cell cycle. In response to double-strand DNA breaks, promotes p53/TP53 phosphorylation on 'Ser-46' and subsequent apoptosis. Acts as a tumor suppressor by inducing cell death by an autophagy and caspase-dependent mechanism. Can reduce cell migration by regulating the expression of SPARC. {ECO:0000269|PubMed:11511362, ECO:0000269|PubMed:22421968, ECO:0000269|PubMed:22470510}.;
- Pathway
- HTLV-I infection - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;TP53 Regulates Transcription of Cell Death Genes;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Direct p53 effectors
(Consensus)
Recessive Scores
- pRec
- 0.280
Intolerance Scores
- loftool
- 0.841
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- 0.404
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.440
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.825
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trp53inp1
- Phenotype
- neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; immune system phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- autophagosome assembly;apoptotic process;cell cycle arrest;negative regulation of cell population proliferation;response to heat;positive regulation of autophagy;negative regulation of gene expression;negative regulation of cell migration;cellular response to UV;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of transcription, DNA-templated;autophagic cell death;negative regulation of fibroblast proliferation;cellular response to ethanol;cellular response to hydroperoxide;cellular response to methyl methanesulfonate;cellular oxidant detoxification;regulation of signal transduction by p53 class mediator;negative regulation of myofibroblast differentiation
- Cellular component
- nucleus;nucleoplasm;autophagosome;cytosol;PML body;cytoplasmic vesicle
- Molecular function
- protein binding;antioxidant activity